Ranibizumab intravitreal injection
Showing 1 - 25 of >10,000
Focal Laser Single Intravitreal Ranibizumab Retinal Artery
Completed
- Retinal Artery Macroaneurysm
- Dual focal laser and intravitreal Ranibizumab injection
-
Cairo, EgyptKasr alainy faculty of medicine
Jan 29, 2023
Retina Disease, Retinopathy of Prematurity, Ranibizumab Trial in Zagazig (Ranibizumab (0.25 mg/0.025 mL))
Completed
- Retina Disease
- +2 more
- Ranibizumab (0.25 mg/0.025 mL)
-
Zagazig, EgyptZagazig University, Faculty of medicine
Jan 26, 2023
Diabetic Macular Edema Trial in Cairo (intra-vitreal injection of Ranibizumab, anterior chamber paracentesis)
Recruiting
- Diabetic Macular Edema
- intra-vitreal injection of Ranibizumab
- anterior chamber paracentesis
-
Cairo, EgyptAin shams university
May 15, 2023
Wet Age-related Macular Degeneration Trial (Ranibizumab, SCT510A)
Not yet recruiting
- Wet Age-related Macular Degeneration
- (no location specified)
Jul 28, 2022
Mild Non-proliferative Diabetic Retinopathy, Cataract Diabetic, Diabetic Retinopathy Trial in Shanghai (Ranibizumab Injection
Recruiting
- Mild Non-proliferative Diabetic Retinopathy
- +2 more
- Ranibizumab Injection [Lucentis]
- Phacoemulsification
-
Shanghai, Shanghai, ChinaDepartment of Ophthalmology, Ruijin Hospital Affiliated Medical,
May 18, 2022
Non-Ischemic Central Retinal Vein Occlusion With Macular Edema Trial in Qina (intravitreal injection of Ranibizumab,
Recruiting
- Non-Ischemic Central Retinal Vein Occlusion With Macular Edema
- intravitreal injection of Ranibizumab
- +3 more
-
Qinā, Qena, EgyptAhmed Ali Ahmed Amer
Mar 15, 2022
Age Related Macular Degeneration Trial in Nedlands (HLX04-O, ranibizumab)
Recruiting
- Age Related Macular Degeneration
-
Nedlands, Western Australia, AustraliaLions Eye Institute
Feb 7, 2022
Neovascular Age-related Macular Degeneration Trial in United States (SUSVIMO (ranibizumab injection), LUCENTIS (ranibizumab
Recruiting
- Neovascular Age-related Macular Degeneration
- SUSVIMO (ranibizumab injection)
- LUCENTIS (ranibizumab injection)
-
Mesa, Arizona
- +32 more
Jan 13, 2023
Proliferative Diabetic Retinopathy Trial in Beijing (preoperative group and intraoperative group)
Completed
- Proliferative Diabetic Retinopathy
- preoperative group and intraoperative group
-
Beijing, Beijing, ChinaPeople's Hospital of Peking University
Jun 1, 2022
Branch Retinal Vein Occlusion, Ranibizumab, Laser Photocoagulation Trial in Beijing (Ranibizumab combined macular laser,
Completed
- Branch Retinal Vein Occlusion
- +2 more
- Ranibizumab combined macular laser
- Ranibizumab
-
Beijing, Beijing, ChinaBeijing Hospital
Dec 25, 2022
Retinopathy of Prematurity Both Eyes Trial in Zagazig (Bevacizumab, Ranibizumab)
Recruiting
- Retinopathy of Prematurity Both Eyes
- Bevacizumab, Ranibizumab
-
Zagazig, EgyptZagazig University
Aug 26, 2021
Diabetic Retinopathy Trial in Nantong (Ranibizumab Injection [Lucentis], Inner limiting membrane stripping, Dexamethasone
Recruiting
- Diabetic Retinopathy
- Ranibizumab Injection [Lucentis]
- +2 more
-
Nantong, Jiangsu, ChinaAffiliated Hospital of Nantong University
Mar 7, 2022
Intravitreal Injection Site and Perceived Pain
Recruiting
- Pain
- Intravitreal injection site
-
Galveston, TexasUniversity of Texas Medical Branch
Jan 19, 2023
OCTA and Polypoidal Choroidal Vasculopathy
Completed
- Polypoidal Choroidal Vasculopathy
- Ranibizumab Injection
-
Naples, ItalyUniversity of Naples "Federico II"
Jan 14, 2021
Diabetic Macular Edema Trial in Giza (Lucentis alone group, Lucentis dexamethasone group)
Completed
- Diabetic Macular Edema
- Lucentis alone group
- Lucentis dexamethasone group
-
Giza, Cairo, EgyptKhaled G Abueleinen
Feb 27, 2022
Pain, Intravitreal Injection, Pain, Acute Trial in Canada, United States (Use of bromfenac 0.09% to reduce intravitreal
Recruiting
- Pain
- +2 more
- Use of bromfenac 0.09% to reduce intravitreal injection pain
- Use of artificial tears to reduce intravitreal injection pain
-
Boston, Massachusetts
- +4 more
Nov 8, 2023
Diabetic Retinopathy, Macular Edema Trial in Cleveland (aflibercept)
Completed
- Diabetic Retinopathy
- Macular Edema
-
Cleveland, OhioCole Eye Institute, Cleveland Clinic
Jan 25, 2021
Wet Age-related Macular Degeneration Trial in Boston, Worcester (Intravitreal anti-VEGF, Intravitreal AAVCAGsCD59, Oral
Completed
- Wet Age-related Macular Degeneration
- Intravitreal anti-VEGF
- +2 more
-
Boston, Massachusetts
- +1 more
May 24, 2022
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Beijing (Intravitreal injection of IBI302(dose 1),
Suspended
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
- Intravitreal injection of IBI302(dose 1)
- +3 more
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jul 17, 2023
Long Term Outcome of Intravitreal Ranibizumab for ROP
Completed
- Retinopathy of Prematurity
- cycloplegic refraction
-
Mansoura, Dakahlia, EgyptMansoura University
Aug 28, 2020
Uveitis, Macular Edema Trial in Worldwide (Dexamethasone intravitreal implant 0.7 mg, Intravitreal Methotrexate 400 µg,
Completed
- Uveitis
- Macular Edema
- Dexamethasone intravitreal implant 0.7 mg
- +2 more
-
Los Angeles, California
- +32 more
Mar 31, 2022
Intravitreal Ranibizumab in Recurrent ROP
Completed
- Retinopathy of Prematurity
- intravitreal injection of Ranibizumab
-
Mansoura, Dakahlia, EgyptMansoura University
Aug 31, 2020
Diabete Type 2, Cataract, Triamcinolone Acetonide Trial in Damascus (Triamcinolone Acetonide)
Completed
- Diabete Type 2
- +3 more
- Triamcinolone Acetonide
-
Damascus, Syrian Arab RepublicDamascus University
Oct 21, 2022
Diabetic Retinopathy, Postoperative Recurrent Vitreous Hemorrhage, Pars Plana Vitrectomy Trial in Tianjin (Ranibizumab
Recruiting
- Diabetic Retinopathy
- +3 more
- Ranibizumab Injection
- PPV
-
Tianjin, Tianjin, ChinaTianjin medical university eye hosipital
Aug 11, 2022
Proliferative Diabetic Retinopathy Trial in Beijing (preoperative intravitreal injections of ranibizumab or conbercept)
Completed
- Proliferative Diabetic Retinopathy
- preoperative intravitreal injections of ranibizumab or conbercept
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jun 7, 2022